FmocL-Tyr(3-NO2)-OH is an Fmoc-protected L-tyrosine derivative bearing a 3-nitro substituent on the phenolic ring, classifying it as a substituted aromatic amino acid suitable for peptide-building chemistry. The molecule contains an Fmoc carbamate protecting group on the amino functionality and a free carboxylic acid, while the side chain presents a phenolic oxygen and a nitro group that modulate polarity and enable distinct aromatic reactivity patterns. In synthesis, it functions as a protected amino acid building block for stepwise peptide assembly (commonly in solid-phase formats) and as a chemical handle for preparing nitro-phenyl-containing peptide analogues for structure-activity studies, labeling strategies, or analytical method development.
CAT No: CP25333
CAS No:136590-09-5
Synonyms/Alias:Fmoc-3-nitro-L-tyrosine;136590-09-5;Fmoc-Tyr(3-NO2)-OH;ST51037597;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-(4-hydroxy-3-nitrophenyl)propanoicacid;AC1MBSU9;47780_ALDRICH;SCHEMBL5062433;47780_FLUKA;CTK3J1816;MolPort-003-725-660;C24H20N2O7;ZINC2555634;ANW-74601;AKOS015837333;AKOS015896045;RTR-004899;AJ-79738;AK-41353;AM015258;KB-77360;TR-004899;FT-0643258;ST24047223;V1170
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-3-nitrotyrosine
FmocL-Tyr(3-NO2)-OH is an Fmoc-protected L-tyrosine derivative bearing a nitro group at the 3-position of the phenolic ring, combining a chiral amino acid core with an aromatic side chain for peptide and medicinal chemistry workflows. The molecule contains an Fmoc carbamate on the α-amino group and a free carboxylic acid, enabling controlled peptide coupling at the C-terminus while preserving side-chain functionality for subsequent transformations. The 3-nitrophenyl substituent introduces strong electron-withdrawing character and can participate in redox and nucleophilic aromatic substitution chemistry after appropriate activation or reduction, while the phenolic oxygen remains protected by the nitro substitution pattern rather than by an additional phenolic protecting group. The stereochemical integrity of the L-configuration supports predictable amide bond formation and stereodefined incorporation into peptide sequences, making the compound a practical chiral building block and functionalized amino acid intermediate.
1. Peptide Synthesis
FmocL-Tyr(3-NO2)-OH is used in peptide synthesis as an Fmoc-protected amino acid building block for introducing a nitro-substituted tyrosine residue into peptide chains. The Fmoc group supports standard base-mediated deprotection to reveal the α-amine for coupling, while the free carboxylic acid participates in amide bond formation with activated carboxyl partners. The 3-nitrophenyl side chain provides an aromatic handle that can be retained during assembly or selectively transformed after peptide elongation, enabling downstream generation of nitro-to-amino or other aromatic derivatives. Stereodefined L-incorporation supports consistent backbone geometry for structure-sensitive peptide studies and peptidomimetic construction. FmocL-Tyr(3-NO2)-OH thus functions as a protected amino acid derivative compatible with iterative solid-phase or solution-phase peptide coupling strategies.
2. Side-Chain Functionalization
FmocL-Tyr(3-NO2)-OH is applied for side-chain functionalization workflows where the 3-nitro substituent serves as a chemically addressable aromatic functionality. The electron-withdrawing nitro group on the tyrosine phenyl ring can undergo controlled reduction to an aniline or can be leveraged for electrophile-driven aromatic transformations depending on the protecting-group and reaction conditions used for the peptide or free amino acid derivative. The presence of an Fmoc-protected α-amine and a carboxylic acid allows the compound to be incorporated into intermediates before conversion, supporting modular synthesis of nitro-functionalized peptide analogs. The aromatic platform also enables attachment of further substituents through derivatization strategies that preserve the stereochemical backbone. FmocL-Tyr(3-NO2)-OH therefore supports amino acid derivatization and functional group installation routes that originate from a chiral amino acid intermediate.
3. SAR Studies
FmocL-Tyr(3-NO2)-OH is used in structure-activity relationship studies to generate libraries of peptide-like scaffolds bearing an electronically modified tyrosine side chain. The 3-nitro group changes aromatic electronics relative to native tyrosine, which can influence hydrogen-bonding patterns, aromatic interactions, and conformational preferences in peptide or peptidomimetic formats. The Fmoc-protected amino acid form enables systematic incorporation into defined sequences, while the free carboxylic acid supports coupling into C-terminal fragments or activated intermediates for SAR panel synthesis. The stereodefined L-configuration helps ensure that observed activity or binding trends correlate with side-chain electronics rather than backbone stereochemical variability. FmocL-Tyr(3-NO2)-OH thereby serves as a functionalized amino acid analog for molecular design and SAR-driven optimization of aromatic residue properties.
4. Chemical Biology Probes
FmocL-Tyr(3-NO2)-OH is suitable for chemical biology probe development where nitroaromatic functionality can be used as a reactive or detectable moiety within peptide conjugates. The compound's Fmoc protection supports controlled assembly into probe scaffolds, while the nitro-substituted tyrosine side chain provides a handle for subsequent chemical modification after conjugation to targets such as proteins, polymers, or affinity tags. The free carboxylic acid enables incorporation into amide-linked probe constructs and supports conversion into activated derivatives for coupling to biomolecule-reactive platforms when downstream steps require it. The aromatic stereochemistry and defined backbone incorporation help maintain consistent recognition elements in probe design. FmocL-Tyr(3-NO2)-OH thus supports biomolecule modification and chemical biology research intermediate preparation for nitroaromatic-containing molecular tools.
5. Pharmaceutical Intermediate Preparation
FmocL-Tyr(3-NO2)-OH is employed in pharmaceutical intermediate preparation for manufacturing routes that require a protected, stereochemically defined nitro-tyrosine building block. The Fmoc-protected amino group and carboxylic acid handle allow conversion into activated coupling partners or protected peptide fragments used in the synthesis of peptide-based candidates and related small-molecule intermediates. The nitro group provides a functional group that can be carried through early steps and later transformed under controlled conditions to access downstream aromatic amine or further substituted motifs, supporting flexible route design. The defined L-stereochemistry supports reproducible incorporation into sequence-defined intermediates used for process chemistry and fine chemical synthesis. FmocL-Tyr(3-NO2)-OH therefore functions as a chiral amino acid intermediate aligned with industrial peptide and functional aromatic intermediate manufacturing needs.
6. Analytical Research Standards
FmocL-Tyr(3-NO2)-OH is used as an analytical research standard and reference material precursor for LC-MS and method development involving nitroaromatic tyrosine-containing peptides and fragments. The Fmoc carbamate and nitro-substituted aromatic side chain provide characteristic mass signatures and fragmentation behavior that can support identification of related derivatized species during peptide synthesis monitoring. The compound's structure enables preparation of defined standards for validating coupling efficiency, deprotection completeness, and side-chain integrity when nitro-functionalized residues are incorporated. The stereodefined L-backbone and fixed substitution pattern help reduce ambiguity in analytical assignments across synthetic batches. FmocL-Tyr(3-NO2)-OH thus supports analytical research and quality-by-design workflows for amino acid derivative and peptide building block characterization.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.